NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $222 | -9.8% | 386 | +10.6% | 0.00% | – |
| Q1 2023 | $246 | -95.1% | 349 | -84.4% | 0.00% | – |
| Q4 2022 | $5,044 | -92.0% | 2,232 | -88.5% | 0.00% | – |
| Q3 2022 | $63,000 | +117.2% | 19,431 | +146.7% | 0.00% | – |
| Q2 2022 | $29,000 | -23.7% | 7,875 | +8.7% | 0.00% | – |
| Q1 2022 | $38,000 | -71.6% | 7,248 | -27.2% | 0.00% | – |
| Q4 2021 | $134,000 | +19.6% | 9,956 | +60.0% | 0.00% | – |
| Q3 2021 | $112,000 | +9.8% | 6,221 | +3.9% | 0.00% | – |
| Q2 2021 | $102,000 | -16.4% | 5,988 | -1.6% | 0.00% | – |
| Q1 2021 | $122,000 | +38.6% | 6,083 | +19.9% | 0.00% | – |
| Q4 2020 | $88,000 | +6.0% | 5,073 | +2.0% | 0.00% | – |
| Q3 2020 | $83,000 | -57.4% | 4,972 | -40.7% | 0.00% | – |
| Q2 2020 | $195,000 | +29.1% | 8,378 | -0.4% | 0.00% | – |
| Q1 2020 | $151,000 | -53.8% | 8,413 | -44.4% | 0.00% | – |
| Q4 2019 | $327,000 | +63.5% | 15,125 | +38.3% | 0.00% | – |
| Q3 2019 | $200,000 | -77.5% | 10,936 | -56.1% | 0.00% | -100.0% |
| Q2 2019 | $887,000 | +139.1% | 24,917 | +125.0% | 0.00% | – |
| Q1 2019 | $371,000 | 0.0% | 11,076 | -1.8% | 0.00% | – |
| Q4 2018 | $371,000 | -43.8% | 11,278 | +4.2% | 0.00% | -100.0% |
| Q3 2018 | $660,000 | -1.6% | 10,827 | -21.3% | 0.00% | 0.0% |
| Q2 2018 | $671,000 | -84.6% | 13,758 | -66.5% | 0.00% | -75.0% |
| Q1 2018 | $4,362,000 | +48.1% | 41,066 | -16.8% | 0.00% | +33.3% |
| Q4 2017 | $2,946,000 | +301.9% | 49,330 | +61.5% | 0.00% | +200.0% |
| Q3 2017 | $733,000 | +37.3% | 30,537 | +11.9% | 0.00% | 0.0% |
| Q2 2017 | $534,000 | -22.4% | 27,285 | -7.0% | 0.00% | 0.0% |
| Q1 2017 | $688,000 | +82.5% | 29,345 | -4.4% | 0.00% | – |
| Q4 2016 | $377,000 | -8.9% | 30,684 | +27.4% | 0.00% | – |
| Q3 2016 | $414,000 | +35.3% | 24,084 | +12.1% | 0.00% | – |
| Q2 2016 | $306,000 | -23.7% | 21,483 | -26.3% | 0.00% | – |
| Q1 2016 | $401,000 | -58.1% | 29,132 | -48.7% | 0.00% | -100.0% |
| Q4 2015 | $957,000 | +63.9% | 56,748 | +6.7% | 0.00% | 0.0% |
| Q3 2015 | $584,000 | -14.5% | 53,176 | -2.7% | 0.00% | 0.0% |
| Q2 2015 | $683,000 | +16.4% | 54,653 | +2.4% | 0.00% | 0.0% |
| Q1 2015 | $587,000 | -41.9% | 53,356 | -18.2% | 0.00% | 0.0% |
| Q4 2014 | $1,011,000 | +28.6% | 65,220 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $786,000 | -7.1% | 64,980 | -1.5% | 0.00% | 0.0% |
| Q2 2014 | $846,000 | -5.9% | 65,980 | -11.0% | 0.00% | 0.0% |
| Q1 2014 | $899,000 | +92.1% | 74,158 | +80.2% | 0.00% | 0.0% |
| Q4 2013 | $468,000 | +67.7% | 41,144 | +53.8% | 0.00% | – |
| Q3 2013 | $279,000 | +99.3% | 26,744 | +122.1% | 0.00% | – |
| Q2 2013 | $140,000 | – | 12,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |